Michael Stojanovic, MD
Orthopaedic Surgery · Omaha, NENPI 1831586866
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (46.3%), education and travel and lodging — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Stryker at 46.5% of the total. Reporting peaked in 2022 at $8,375 and has fallen 88.6% since, to $954 in 2025.
Across 167 payments — averaging $133.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$10K
- Smith+Nephew$6K
- Medical Device Business Services, Inc.$2K
- Gemini Medical LLC$2K
- Johnson & Johnson$1K
- Medtronic$1K
- plus $208 from 4 others
What the payments were for
- Consulting fees$9304%
- Travel & lodging$3,18814%
- Food & beverage$10,31446%
- Education$7,83035%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 124 | $10,343 |
| Smith+Nephew | 7 | $6,237 |
| Medical Device Business Services, Inc. | 10 | $1,660 |
| Gemini Medical LLC | 1 | $1,545 |
| Johnson & Johnson | 12 | $1,254 |
| Medtronic | 9 | $1,014 |
| Heron Therapeutics, Inc. | 1 | $80 |
| Bioventus LLC | 1 | $80 |
| Vericel Corporation | 1 | $24 |
| Biocomposites Inc | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$4,431
- TRIATHLON$1,251
- VARIAX$1,075
- T2$938
- RESTORATION$785
- AQUAMANTYS$623
- ACCOLADE$342
- INSIGNIA$292
- PRIME SERIES$268
- GAMMA$229
- AqWire$147
- PANGEA$131
- PICO$128
- TFN-Advance$118
- AUGMENT INJECTABLE$107
- AXSOS$107
- HOFFMANN$107
- MEDTRONIC REUSABLE INSTRUMENTS$104
How this compares
$22,262 in reported general payments places this provider in the 85th percentile of 155 orthopaedic surgery providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 178 | $402 |
| Methylprednisolone | 28 | $223 |
| Celecoxib | 11 | $167 |
| Tramadol Hcl | 30 | $104 |
| Oxycodone Hcl | 12 | $68 |
| Amoxicillin | 11 | $11 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Omaha
- Edward FehringerOmaha$2M
- Joshua UrbanOmaha$475K
- Sayfe JassimOmaha$460K
- Beau KildowOmaha$353K
- Matthew DilisioOmaha$58K
- Samuel DubrowOmaha$34K
- Jonathan BuzzellOmaha$33K
- Kirk HuttonOmaha$15K
- Sean McGarryOmaha$12K
- Clayton ThorOmaha$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.